Your Article Summary
See Latest ArticlesCost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India
Tropical Medicine & International Health, 07/02/09
Olliaro P et al. - The available treatments for VL are cost-effective, and the mortality and incidence-based methods produce consistent estimates. The combinations considered here were more cost-effective than most monotherapies. Having multiple treatment options and combining drugs are also likely to reduce drug pressure and prolong the drugs' life-span of effective use.
Related Articles
Cutaneous leishmaniasis treated with itraconazole
Dermatologic Therapy, 11/20/09
Relevance Score: 85%
Cutaneous and mucocutaneous leishmaniasis
Dermatologic Therapy, 11/20/09
Relevance Score: 85%
Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent
Tropical Medicine & International Health, 11/17/09
Relevance Score: 84%
Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09
Relevance Score: 84%
The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells
Antimicrobial Agents and Chemotherapy, 11/20/09
Relevance Score: 83%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources
Tropical Medicine & International Health, 12/10/09
Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden
American Journal of Epidemiology, 12/10/09
IFI = invasive fungal infections. What is that? A misnomer, because a non-invasive fungal infection does not exist
International Journal of Infectious Diseases, 12/10/09